147 related articles for article (PubMed ID: 10530702)
21. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553
[TBL] [Abstract][Full Text] [Related]
22. Topical amiloride accelerates healing and delays neovascularization in mechanically produced corneal ulcers in rabbits.
Sood AK; Gupta B; Chugh P
Methods Find Exp Clin Pharmacol; 1999 Sep; 21(7):491-7. PubMed ID: 10544394
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy for ocular angiogenesis.
Bainbridge JW; Mistry AR; Thrasher AJ; Ali RR
Clin Sci (Lond); 2003 Jun; 104(6):561-75. PubMed ID: 12570869
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.
Lai CM; Brankov M; Zaknich T; Lai YK; Shen WY; Constable IJ; Kovesdi I; Rakoczy PE
Hum Gene Ther; 2001 Jul; 12(10):1299-310. PubMed ID: 11440623
[TBL] [Abstract][Full Text] [Related]
25. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution.
Ingber DE; Madri JA; Folkman J
Endocrinology; 1986 Oct; 119(4):1768-75. PubMed ID: 2428602
[TBL] [Abstract][Full Text] [Related]
26. Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model.
Mirabelli P; Peebo BB; Xeroudaki M; Koulikovska M; Lagali N
Exp Eye Res; 2014 Aug; 125():118-27. PubMed ID: 24933712
[TBL] [Abstract][Full Text] [Related]
27. Gene transfer for the treatment of neovascular ocular disease (an American Ophthalmological Society thesis).
Stout JT
Trans Am Ophthalmol Soc; 2006; 104():530-60. PubMed ID: 17471360
[TBL] [Abstract][Full Text] [Related]
28. Angiostatic steroids. Method of discovery and mechanism of action.
Folkman J; Ingber DE
Ann Surg; 1987 Sep; 206(3):374-83. PubMed ID: 2443088
[TBL] [Abstract][Full Text] [Related]
29. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
30. Angiostatic activities of medroxyprogesterone acetate and its analogues.
Yamamoto T; Terada N; Nishizawa Y; Petrow V
Int J Cancer; 1994 Feb; 56(3):393-9. PubMed ID: 7508892
[TBL] [Abstract][Full Text] [Related]
31. A quantitative angiogenesis model for efficacy testing of chemopreventive agents.
Sharma S; Ghoddoussi M; Gao P; Kelloff GJ; Steele VE; Kopelovich L
Anticancer Res; 2001; 21(6A):3829-37. PubMed ID: 11911254
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis inhibition by the maleimide-based small molecule GNX-686.
Nowak-Sliwinska P; Storto M; Cataudella T; Ballini JP; Gatz R; Giorgio M; van den Bergh H; Plyte S; Wagnières G
Microvasc Res; 2012 Mar; 83(2):105-10. PubMed ID: 22056402
[TBL] [Abstract][Full Text] [Related]
33. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane.
Nap AW; Dunselman GA; Griffioen AW; Mayo KH; Evers JL; Groothuis PG
Fertil Steril; 2005 Mar; 83(3):793-5. PubMed ID: 15749522
[TBL] [Abstract][Full Text] [Related]
34. [Emoxipin as an inhibitor of angiogenesis].
Sologub AA; Akberova SI; Ziangirova GG
Biull Eksp Biol Med; 1992 Dec; 114(12):620-2. PubMed ID: 1284038
[TBL] [Abstract][Full Text] [Related]
35. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis.
Ribatti D; Vacca A; Roncali L; Dammacco F
Int J Dev Biol; 1996 Dec; 40(6):1189-97. PubMed ID: 9032025
[TBL] [Abstract][Full Text] [Related]
36. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V.
Wang Z; Zhao H; Ma JX; Xu X
Cornea; 2014 Apr; 33(4):405-13. PubMed ID: 24452210
[TBL] [Abstract][Full Text] [Related]
38. [Fibrinolysis components and angiogenesis regulation by example of burn-induced corneal neovascularization in rabbits].
Chesnokova NB; Aĭsina RB; Mukhametova LI; Pavlenko TA; Gulin DA; Beznos OV
Vestn Oftalmol; 2012; 128(4):62-5. PubMed ID: 22994111
[TBL] [Abstract][Full Text] [Related]
39. Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization.
Zahn G; Vossmeyer D; Stragies R; Wills M; Wong CG; Löffler KU; Adamis AP; Knolle J
Arch Ophthalmol; 2009 Oct; 127(10):1329-35. PubMed ID: 19822850
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin.
Wilks JW; Scott PS; Vrba LK; Cocuzza JM
Int J Radiat Biol; 1991; 60(1-2):73-7. PubMed ID: 1713944
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
